Cure for cancer?

Fonction News

Test results of the Swiss pharmaceutical Roche's new drug, Tarceva' have shown that it could help treat advanced pancreatic and lung cancers. Such treatments for Pancreatic cancer, which strikes 60,000 people every year in Europe alone, have been quite limited so far.

The study was carried out together with Genentech and OSI Pharmaceuticals and has demonstrated a statistically significant 23.5 per cent improvement in overall survival for patients who received Tarceva and another drug, gemcitabine, compared...

Pour continuer la lecture


VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT